TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2024-03-27
吳造中Wu, Chau-Chung
- 計畫主持人
- 執行臨床試驗年資 23 年 9 個月
-
r204.cc01@gmail.com
發表文獻
25筆
21
Lin CH, Li CH, Yang KC, Lin FJ, Wu CC, Chieh JJ, Chiu MJ. Blood NfL: A biomarker for disease severity and progression in Parkinson disease. Neurology. 2019 Sep 10;93(11):e1104-e1111. doi: 10.1212/WNL.0000000000008088. Epub 2019 Aug 16. PMID: 31420461.
22
Hsu CY, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Chou RH, Huang CY, Huang PH, Leu HB, Yin WH, Wu CC, Lin SJ, Chen JW. Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients With Stable Coronary Artery Disease. Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1240-1252. doi: 10.1161/ATVBAHA.118.312166. PMID: 30943772.
23
Leu HB, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Cheng Chang K, Wang JH, Wu CC, Chen JW. Impact of type D personality on clinical outcomes in Asian patients with stable coronary artery disease. J Formos Med Assoc. 2019 Mar;118(3):721-729. doi: 10.1016/j.jfma.2018.08.021. Epub 2018 Sep 19. PMID: 30243505.
24
Lue LF, Pai MC, Chen TF, Hu CJ, Huang LK, Lin WC, Wu CC, Jeng JS, Blennow K, Sabbagh MN, Yan SH, Wang PN, Yang SY, Hatsuta H, Morimoto S, Takeda A, Itoh Y, Liu J, Xie H, Chiu MJ. Corrigendum: Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal Subjects. Front Aging Neurosci. 2019 Nov 8;11:292. doi: 10.3389/fnagi.2019.00292. Erratum for: Front Aging Neurosci. 2019 Sep 03;11:222. PMID: 31754353; PMCID: PMC6856676.
25
Tsai HS, Tseng WK, Yin WH, Lin FJ, Hsuan CF, Wu YW, Huang LC, Lin TH, Chang KC, Li YH, Yeh HI, Chen JW, Wu CC; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators. The Correlation between Waist-Hip Ratio and Achieving Therapeutic Lipid Goals in Taiwan. Acta Cardiol Sin. 2019 Nov;35(6):605-614. doi: 10.6515/ACS.201911_35(6).20190403A. PMID: 31879512; PMCID: PMC6859101.
